Skip to main content

Table 2 Participant characteristics

From: Mindfulness-based interventions in epilepsy: a systematic review

 

Thompson et al. (2010) [34]

Thompson et al. (2015) [35]

Tang et al. (2015) [36]

Intervention

Control

Intervention

Control

Intervention

Control

Number of Participants

26

27

62

56

30

30

Number of participants (% female)

20 (77%)

23 (85%)

-- (65.3%)

16 (53.3%)

16 (53.3%)

Mean age (SD)

36.4 years

35.4 years

41.2 years

34.77 years (10.26)

35.47 years (11.22)

Ethnicity

20 (77%) White

6 (23%) African American

19 (70%) White

7 (26%) African American

1 (4%) Other

70 (59.3%) Caucasian

14 (11.9%) African American

3 (2.5%) Hispanic

6 (5.1%) Other race

NR

NR

Socio-economic status

NR

NR

NR

NR

NR

Employment status

12 (52%) Not working/retired

7 (30%) Full Time

3 (13%) Part Time

1 (4%) Student

12 (50%) Not working/retired

6 (25%) Full Time

3 (13%) Part Time

3 (13%) Student

NR

56.7% Full Time

53.3% Full Time

Educational status

7 (30%) High School or less

6 (26%) Completed some college

9 (39%) Graduated college or more

6 (25%) High School or less

9 (38%) Completed some college

9 (38%) Graduated college or more

NR

76.7% (>11 years of education)

80% (>11 years of education)

Living arrangement

17 (74%) Immediate Family

3 (13%) Alone

2 (9%) Friend/roommate/partner

16 (67%) Immediate family

2 (8%) Alone

6 (25%) Friend/roommate/partner

NR

NR

NR

Medications

9 (39%) Antidepressants

9 (37%) Antidepressants

30.5% Antidepressants

50% Carbamazepine

30% Valproate

30% Levetiracetam

26.7% Lamotrigine

40% Carbamazepine

36.7% Valproate

26.7% Levetiracetam

26.7% Lamotrigine

Co-morbidities

10 (44%) MDD

9 (38%) MDD

NR

3 (10%) Concomitant Psychiatric Illness

5 (16.7%) Concomitant Non-Psychiatric Illness

2 (6.7%) Concomitant Psychiatric Illness

5 (16.7%) Concomitant Non-Psychiatric Illness

Mood and Quality of Life Baseline Measures

 mBDI

31.1

27.9

20.3

20.2

N/A

N/A

 BDI

15.2

12.4

7.3

7.2

N/A

N/A

 NDDI-E

N/A

N/A

13.1

13.0

N/A

N/A

 PHQ-9

N/R

N/R

6.7

5.8

N/A

N/A

 QOLIE-31-P

N/A

N/A

N/A

N/A

57.14

59.34

 BAI

N/A

N/A

N/A

N/A

15.10

13.53

 BDI-II

N/A

N/A

N/A

N/A

12.43

13.53

  1. BAI Beck Anxiety Inventory, BDI Beck Depression Inventory, BDI-II Beck Depression Inventory II, MDD Major Depressive Disorder, mBDI modified Beck Depression Inventory, NDDI-E Neurological Disorders Depression Inventory for Epilepsy, N/A Not Applicable, NR Not Reported, PHQ-9 Patient Health Questionnaire 9, QOLIE-31-P Quality of Life in Epilepsy Inventory
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us